Francine Foss, MD
Medical Oncology · New Haven, CTNPI 1104814888
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Seagen Inc. at 29.9% of the total. Among medical oncology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 159 payments — averaging $1213.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$58K
- Acrotech Biopharma Inc.$43K
- Mallinckrodt Enterprises LLC$33K
- Kyowa Kirin, Inc.$28K
- Takeda Pharmaceuticals U.S.A., Inc.$6K
- Aurobindo Pharma USA, Inc.$6K
- plus $19K from 11 others
Across 388 payments — averaging $4794.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Kyowa Kirin, Inc.$866K
- Eisai Inc.$317K
- Otsuka Pharmaceutical Co., Ltd.$317K
- Daiichi Sankyo Inc.$212K
- Seagen Inc.$73K
- Taiho Oncology, Inc.$26K
- plus $49K from 4 others
What the payments were for
- Consulting fees$68,67836%
- Speaking & faculty fees$101,02452%
- Travel & lodging$18,3219%
- Food & beverage$4,8533%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 52 | $57,652 |
| Acrotech Biopharma Inc. | 27 | $42,926 |
| Mallinckrodt Enterprises LLC | 11 | $33,499 |
| Kyowa Kirin, Inc. | 30 | $27,646 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $6,426 |
| Aurobindo Pharma USA, Inc. | 4 | $5,950 |
| Daiichi Sankyo Inc. | 9 | $4,962 |
| Helsinn Healthcare SA | 1 | $4,500 |
| Verastem, Inc. | 2 | $2,739 |
| Otsuka Pharmaceutical Co., Ltd. | 1 | $2,200 |
| Secura Bio, Inc. | 8 | $1,924 |
| Kyowa Kirin Services Ltd | 1 | $1,692 |
| Pfizer | 4 | $359 |
| AstraZeneca | 2 | $225 |
| TG Therapeutics, Inc. | 1 | $120 |
| Eisai Inc. | 1 | $31 |
| Therakos LLC | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$192,876 in reported general payments places this provider in the 90th percentile of 79 medical oncology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JakafiRuxolitinib Phosphate | 13 | $225,427 |
| ZolinzaVorinostat | 12 | $84,195 |
| Bexarotene | 28 | $83,432 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $4,552 |
| Acyclovir | 65 | $869 |
| Levothyroxine Sodium | 25 | $371 |
| Ursodiol | 14 | $368 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 36 | $347 |
| Prednisone | 41 | $303 |
| Cefazolin Sodium | 11 | $300 |
| Potassium Chloride | 27 | $184 |
| Triamcinolone Acetonide | 23 | $183 |
| Hydroxyzine Hcl | 13 | $113 |
| Pantoprazole Sodium | 16 | $105 |
| Rosuvastatin Calcium | 13 | $84 |
Paid to pharmacies, not to this prescriber.
Other medical oncology in New Haven
- Peter MarksNew Haven$578K
- Daniel PetrylakNew Haven$446K
- Mandar MuzumdarNew Haven$371K
- Barbara BurtnessNew Haven$297K
- Ian KropNew Haven$219K
- Anne ChiangNew Haven$158K
- Mario SznolNew Haven$157K
- Lajos PusztaiNew Haven$152K
- Howard HochsterNew Haven$133K
- Sarah GoldbergNew Haven$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.